June 5, 2020 / 11:36 AM / a month ago

BRIEF-Macrogenics Reports Margetuximab Granted Orphan Drug Status For Gastric Cancer

June 5 (Reuters) - MacroGenics Inc:

* MACROGENICS ANNOUNCES MARGETUXIMAB GRANTED ORPHAN DRUG DESIGNATION IN THE U.S. FOR GASTRIC CANCER Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below